Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Dec;21(12):1235-41.
doi: 10.1111/j.1525-1497.2006.00597.x.

Effect of dysthymia on receipt of HAART by minority HIV-infected women

Barbara J Turner  1 , John A Fleishman
Affiliations

Effect of dysthymia on receipt of HAART by minority HIV-infected women

Barbara J Turner et al. J Gen Intern Med. 2006 Dec.

Abstract

Background: Receipt of highly active antiretroviral therapy (HAART) differs by gender and racial/ethnic group and may reflect an effect of mood disorders.

Objective: We examined the effects of dysthymia and major depression on HAART use by 6 groups defined by gender and race/ethnicity (white, black, Hispanic).

Main outcome measure: Self-reported HAART use in the past 6 months.

Data source: Interview data from the HIV Cost and Services Utilization Study (HCSUS). Independent variables measured in or before the first half of 1997, and HAART use measured in the second half of 1997.

Analyses: Multivariate logistic regression of depression and dysthymia on HAART use by 6 patient groups.

Participants: One thousand nine hundred and eighty-two HIV-infected adults in HIV care in 1996 and with a CD4 count <500 in 1997.

Results: Highly active antiretroviral therapy receipt was the highest for white men (68.6%) and the lowest for Hispanic women (52.7%) and black women (55.4%). Dysthymia was more prevalent in women (Hispanic, 46%; black, 27%; white, 31%) than men (Hispanic, 23%; black, 18%; white, 15%). The prevalence of major depression was greater in whites (women, 35%; men, 31%) than minorities (women, 26%; men, 21%). Compared with white men without dysthymia, the adjusted odds ratios (AORs) of HAART were significantly lower for black women (0.50 [95% confidence interval [95% CI] 0.29 to 0.87]) and Hispanic women (0.45 [95% CI 0.25, 0.79]). Among patients with depression and no dysthymia, minority women had HAART use (AOR=1.28 [95% CI 0.48 to 3.43]) similar to white men.

Limitations: Self-report data from the early era of HAART use; causation cannot be proven; mental health diagnoses may not meet full DSM IV criteria.

Conclusions: Dysthymia is highly prevalent in minority women and associated with a 50% reduction in the odds of receiving HAART. This underrecognized condition may contribute more than depression to the "gender disparity" in HAART use.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Adjusted odds ratios for highly active antiretroviral therapy (HAART) use by gender-race/ethnicity-dysthymia status.
FIGURE 2
FIGURE 2
Adjusted odds ratios for highly active antiretroviral therapy (HAART) use by gender-race/ethnicity-depression status.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Cunningham WE, Markson LE, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. J Acquir Immune Defic Syndr. 2000;25:115–23. - PubMed
    1. Laine C, Hauck WW, Turner BJ. Outpatient patterns of care and longitudinal intensity of antiretroviral therapy for HIV-infected drug users. Med Care. 2002;40:976–95. - PubMed
    1. McNaghten AD, Hanson DL, Dworkin MS, Jones JL. Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients. J Acquir Immune Defic Syndr. 2003;32:499–55. - PubMed
    1. Anderson KH, Mitchell JM. Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival. Arch Intern Med. 2000;160:3114–20. - PubMed
    1. Giordano TP, White AC, Jr., Sajja P, et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr. 2003;32:399–405. - PubMed

Publication types

MeSH terms